The finding of such an unusual hDAT mutant capable of increasing the Vmax of hDAT for dopamine uptake while effectively attenuating Tat-induced inhibition of dopamine uptake may provide an exciting knowledge basis for development of novel concepts for therapeutic treatment of the HAND. The gene discussed is TAT; the disease is HIV-associated neurocognitive disorder.